← Back to catalogue
Anti-Neutrophil Cytoplasmic Antbodies (anca)
EUDAMEDClass IVD General (EU MDR)
Ref 44911Ref 44851Ref 55566Ref 44850Ref 44852
Identity
- Device Name
- ANTI-NEUTROPHIL CYTOPLASMIC ANTBODIES (ANCA) EUDAMED
- Model / Reference
- 44911 EUDAMED44851 EUDAMED55566 EUDAMED44850 EUDAMED44852 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 08435287106602 EUDAMED08435287148510 EUDAMED08012992555668 EUDAMED08435287148503 EUDAMED08435287148527 EUDAMED
- Basic UDI-DI
- B-08435287106602 EUDAMEDB-08435287148510 EUDAMEDB-08012992555668 EUDAMEDB-08435287148503 EUDAMEDB-08435287148527 EUDAMED
- EMDN Code
- W0102100499 VASCULITIS - OTHER EUDAMED
Classification
- Device Class
- Class IVD General EUDAMED
- Market of Registration
- Spain EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Human Tissues
Yes
EUDAMED
Animal Tissues
Yes
EUDAMED
Microbial Substances
No
EUDAMED
Reagent
Yes
EUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
Yes
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
New Device
No
EUDAMED
Anti-Neutrophil Cytoplasmic Antbodies (anca) by Biosystems S.a. — Class IVD General — IVDD — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDD | B-08435287106602 | Class IVD General | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biosystems S.a.
- EUDAMED SRN
- ES-MF-000000231
Sources (5)
- EUDAMED 9e84d9c6-64a4-4aa9-8dec-9d4c55fcd2cb 61 fields · synced Sep 17, 2026
- EUDAMED 8516692c-ea45-4a21-9d1d-59f003810a60 61 fields · synced May 16, 2026
- EUDAMED e3cc058d-de3f-45be-8a5f-30385a7b7f77 61 fields · synced May 18, 2026
- EUDAMED 3d108b02-d482-48b1-b870-8529c28b15ac 61 fields · synced May 18, 2026
- EUDAMED 43cdd426-5d71-49f4-96de-cac449c11395 61 fields · synced May 18, 2026